Resveratrol, Metabolic Syndrome, and Gut Microbiota – Nov 2018

Nutrients. 2018 Nov 3;10(11). pii: E1651. doi: 10.3390/nu10111651.
Chaplin A1, Carpéné C2, Mercader J3,4.

 Download the PDF from VitaminDWiki
Image

Resveratrol is a polyphenol which has been shown to have beneficial effects on metabolic syndrome-related alterations in experimental animals, including glucose and lipid homeostasis improvement and a reduction in fat mass, blood pressure, low-grade inflammation, and oxidative stress. Clinical trials have been carried out to address its potential; however, results are still inconclusive. Even though resveratrol is partly metabolized by gut microbiota, the relevance of this "forgotten organ" had not been widely considered. However, in the past few years, data has emerged suggesting that the therapeutic potential of this compound may be due to its interaction with gut microbiota, reporting changes in bacterial composition associated with beneficial metabolic outcomes. Even though data is still scarce and for the most part observational, it is promising nevertheless, suggesting that resveratrol supplementation could be a useful tool for the treatment of metabolic syndrome and its associated conditions.

3209 visitors, last modified 25 Feb, 2021,
Printer Friendly Follow this page for updates